The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Nad-Augmentation Therapy For Parkinson'S Disease - EP4284387

The patent EP4284387 was granted to Vestlandets Innovasjonsselskap VIS on Jul 31, 2024. The application was originally filed on Jun 24, 2022 under application number EP22740800A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4284387

VESTLANDETS INNOVASJONSSELSKAP VIS
Application Number
EP22740800A
Filing Date
Jun 24, 2022
Status
Granted And Under Opposition
Jun 27, 2024
Publication Date
Jul 31, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

IMMUNOPHARMAApr 29, 2025WEICKMANN & WEICKMANN PARTMBBADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2018039207
INTERNATIONAL-SEARCH-REPORTWO2020257283
INTERNATIONAL-SEARCH-REPORTWO2022028678
OPPOSITIONUS4970200
OPPOSITIONWO2013045538
OPPOSITIONWO2018039207

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents